Company: PTHS
Filing Date: 2025-05-09
Form Type: PREM14C
Source: 0001140361-25-018219
Chunk: 496

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-09
Form: PREM14C
Chunk 496
---
 of $131,868 and accrued interest of $4,242. Outstanding Principal on Related Party Notes

| Note Payable - Related Party  |     | Outstanding 
   Principal |     | Unamortized   
 Debt Discount |     |       Outstanding 
 Principal, net of 
     Debt Discount |
| Related Party Note            |     |    $131,868 |     | $—            |     |          $131,868 |
| Total as of December 31, 2024 |     |    $131,868 |     | $—            |     |          $131,868 |

F-14

TABLE OF CONTENTS

| Note Payable - Related Party          |     | Outstanding 
   Principal |     |   Unamortized 
 Debt Discount |     |       Outstanding 
 Principal, net of 
     Debt Discount |
| Director Note                         |     |    $175,000 |     |            $— |     |          $175,000 |
| September and April Bridge financings |     |     596,928 |     |       -21,846 |     |           575,082 |
| Total as of December 31, 2023         |     |    $771,928 |     |     $(21,846) |     |          $750,082 |

NOTE 5 - NOTES PAYABLE Investor Note On February 4, 2022, the Company entered into a note payable for $450,000 (the “Investor Note”) with a third party. This Investor Note had an original issuance discount of $150,000, representing an implicit interest rate of 50%, a maturity date of February 3, 2023, and accrues no interest beyond the original issuance discount. During the year ended December 31, 2024, the Company issued 81,112 shares of common stock to extend the maturity date of the note, resulting in an additional debt discount of $447,379. The Company recognized $581,055 and $309,094, respectively, of amortization of debt discount included in interest expense on the statement of operations for the years ended December 31, 2024 and 2023 related to the Investor Note. As of December 31, 2024, the debt discount associated with this Investor Note was fully amortized. On February 27, 2023, the Investor Note was amended. The maturity date was extended from its original due date of February 3, 2023 to May